Skip to content

Investigating the Impact of Virtual Reality Technology on Anxiety Levels and Hemodynamic Indices in Cancer Patients during Chemotherapy

Investigating the Impact of Virtual Reality Technology on Anxiety Levels and Hemodynamic Indices in Cancer Patients during Chemotherapy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20260209068819N1
Enrollment
54
Registered
2026-02-14
Start date
2026-03-06
Completion date
Unknown
Last updated
2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer patients undergoing chemotherapy.

Interventions

Intervention 1: Intervention group: During a chemotherapy session, for patients in the intervention group, the demographic questionnaire and the Spielberger State Anxiety Inventory will be completed 1
immediately after removal of the headset, hemodynamic parameters will be re-measured and the Spielberger State Anxiety Inventory will be administered again. Intervention 2: Control group: During a che
the same hemodynamic parameters and the Spielberger State Anxiety Inventory will be re-assessed and recorded 30 minutes after the start of chemotherapy.

Sponsors

Islamic Azad University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Having a confirmed diagnosis of cancer Receiving chemotherapy Being between 18 and 75 years of age Being oriented to time and place Possessing adequate verbal communication skills The ability to understand and respond to the Spielberger State Anxiety Inventory questionnaire

Exclusion criteria

Exclusion criteria: Having no history of severe visual, psychological, or neurological disorders, migraine headaches, or seizures No prior use of sedative or anti-anxiety medications Absence of implanted medical devices such as pacemakers or hearing aids

Design outcomes

Primary

MeasureTime frame
The anxiety level of cancer patients undergoing chemotherapy will be measured using the Spielberger State Anxiety Inventory, with total scores ranging from 20 (lowest anxiety) to 80 (highest anxiety). Timepoint: During a chemotherapy session, the demographic questionnaire and the Spielberger State Anxiety Inventory will be completed for patients in both the control and intervention groups 10 minutes prior to the initiation of chemotherapy drug infusion. The intervention group will then use a virtual reality headset for 30 minutes during the chemotherapy drug infusion to reduce anxiety; immediately after removal of the headset, the Spielberger State Anxiety Inventory will be completed again. Patients in the control group will not receive any intervention and will undergo routine chemotherapy; immediately 30 minutes after the start of chemotherapy, the Spielberger State Anxiety Inventory will be recorded. Method of measurement: The patients’ level of anxiety will be measured using the Spielberger State Anxiety Inventory (consisting of 20 items). Each item of the instrument is presented in either a positively- or negatively-worded form. Each item is scored on a 1–4 scale according to the respondent’s answer, with items that indicate the presence of anxiety scored from 1 to 4 and items that indicate the absence of anxiety reverse-scored from 4 to 1. The positively-worded items (1, 2, 5, 8, 10, 11, 15, 16, 19, 20) are scored as: very little (4), little (3), much (2), and very much (1). The negatively-worded items (3, 4, 6, 7, 9, 12, 13, 14, 17, 18) are scored as: very little (1), little (2), much (3), and very much (4).;Hemodynamic indices will be measured, including systolic and diastolic blood pressure, mean arterial pressure, oxygen saturation, pulse, respiratory rate, and body temperature. Timepoint: During a chemotherapy session, systolic and diastolic blood pressure, mean arterial pressure, oxygen saturation, pulse rate, respiratory rate, and body temperature will

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaral Karim

Islamic Azad University

maral.karim@iau.ir+98 21 2200 4355

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Jun 11, 2026